Efficacy of misoprostol before diagnostic hysteroscopy in postmenopausal women: A randomized clinical trial
Menopause Jun 27, 2018
Nakano FA, et al. - In this randomized, double-blind, placebo-controlled clinical trial, researchers evaluated pain and determined the efficacy of misoprostol, compared with placebo, for postmenopausal women before diagnostic hysteroscopy. They analyzed 158 postmenopausal women who received either 200 μg of misoprostol or placebo through the vaginal route before diagnostic hysteroscopy (79 women/group). Outcomes suggested that misoprostol results in no reduction in pain intensity, the duration of the procedure, or need for additional cervical dilatation. in addition, more adverse effects were also noted with it when used in these women before diagnostic hysteroscopy
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries